-
Welcome to Kazia Therapeutics
-
Kazia is a new company, with great potential in its pipeline, a clear strategy to realise value for shareholders, and a lean team with the experience and expertise to deliver benefit to patients.
-
Events
19-Feb-2019
Melbourne Proactive Investors CEO Session
19th February from 12-noon to 2pm
CQ Melbourne, Events Room 1 (113 Queen Street, Melbourne)
Register here by 15th February to attend.
More Events
Insights
14-Feb-2019New
February 2019 Shareholder Newsletter
13-Feb-2019New
Dr Alan Olivero discusses what makes a good brain cancer drug
More Insights
-
Resources
31-Oct-2018
Edison Research - New indications for GDC-0084
24-Sep-2018
Edison Research - GDC-0084 and Cantrixil trials progressing
14-MAY-2018
Edison Research - GDC-0084 Phase II underway
